You have developed a digital health application (DiGA) and want to know whether you are optimally prepared for submitting an application to the BfArM? Check your current status and fill out our interactive questionnaire. You will answer in approx. 5 minutes only the questions that are relevant for you.
Reimbursement of digital health applications – DiGA or “apps on prescription” – is now possible within the German health system.
Is dealing with the legal framework of the SGB V (German Social Security Code) and meeting the requirements and criteria for the new fast-track reimbursement process completely new territory for you as a developer or provider?
In our opinion, market knowledge of the German healthcare system and expertise in market access are essential for successful applications.
Together with figus we prepare the way for your health apps to enter the German market. We offer you a range of services tailored to your individual needs, from potential analysis, study design and evaluation to the best possible pricing strategy.
In this way we support you as your professional partner and consultant from the beginning to include your health app into the DiGA directory.
To better illustrate the BfArM process, we have put together a PDF for you:
How do we do this?
Is your application “DiGA compatible”? Has your application been sufficiently prepared for BfArM? Check your current status and fill out the interactive questionnaire. You only need to answer the questions that are relevant for you.
After you have completed the questionnaire, we will contact you within two working days to arrange an initial consultation free of charge. This will give you an overview of the necessary next steps for you and your investors.
After the initial consultation, we offer you a strategy workshop to determine your individual needs and develop recommendations for the next steps. If necessary, this can be done on short notice (two weeks).
Taking your individual needs into account, we support you in having your app included in the DiGA directory and in subsequent price negotiations.
In cooperation with figus